Phys. Rev. ST Accel. Beams 10, 054701 (2007) [8 pages]

Hadron cancer therapy complex using nonscaling fixed field alternating gradient accelerator and gantry design

Abstract
No Citing Articles
Download: PDF (1078 kB) , One-column PDF (1084 kB), or gzip'ed PS (3094 kB) Export: BibTeX or EndNote (RIS)

E. Keil *
CERN, Geneva, Switzerland

A. M. Sessler
Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA

D. Trbojevic
Brookhaven National Laboratory, Upton, New York 11973, USA

Received 7 September 2006; published 29 May 2007

Nonscaling fixed field alternating gradient (FFAG) rings for cancer hadron therapy offer reduced physical aperture and large dynamic aperture as compared to scaling FFAGs. The variation of tune with energy implies the crossing of resonances during acceleration. Our design avoids intrinsic resonances, although imperfection resonances must be crossed. We consider a system of three nonscaling FFAG rings for cancer therapy with 250 MeV protons and 400   MeV/u carbon ions. Hadrons are accelerated in a common radio frequency quadrupole and linear accelerator, and injected into the FFAG rings at v/c=0.1294. H+/C6+ ions are accelerated in the two smaller/larger rings to 31 and 250  MeV/68.8 and 400   MeV/u kinetic energy, respectively. The lattices consist of doublet cells with a straight section for rf cavities. The gantry with triplet cells accepts the whole required momentum range at fixed field. This unique design uses either high-temperature superconductors or superconducting magnets reducing gantry magnet size and weight. Elements with a variable field at the beginning and at the end set the extracted beam at the correct position for a range of energies.


©2007 The American Physical Society

URL: http://link.aps.org/abstract/PRSTAB/v10/e054701
DOI: 10.1103/PhysRevSTAB.10.054701
PACS: 29.20.−c, 29.27.Eg, 41.75.Ak

* Electronic address: Eberhard.Keil@t-online.de

[ Abstract  |  Previous article  |  Next article  |  Issue 5 ]